Menotropins is a purified combination of human luteinizing hormone and follicle stimulating hormone used to treat female infertility. It is used as a fertility medication that is injected either subcutaneously or intramuscularly.
- Mechanism
- Curator reviewed
Being a combination drug, Menotropins bind to the follicle stimulating hormone receptor (FSH), which results in ovulation in the absence of sufficient endogenous luteinizing hormone (LH). It also binds the LH receptor, thereby stimulating proper hormone release. The drug contains both FSH and LH, therefore, it induces ovarian follicular growth and development as well as gonadal steroid production in women who do not have ovarian failure. FSH is the primary driver of follicular recruitment and growth in early folliculogenesis, while LH is important for ovarian steroidogenesis and is involved in the physiological events leading to development of a competent pre-ovulatory follicle.
- Primary indication
- For the treatment of female infertilityCurator reviewed · 1 structured indication
- Formula / weight
- C1014H1609N287O294S27 · 23390.3 Da
- First approval
- Canada, 2006
- Also known as
- Human menopausal gonadotrophin · Menotrophin · Menotropin · Menotropins (FSH;LH)
- Brand names
Resolves to
What you can answer from here — as of July 17, 2026
Which drugs share a target with Menotropins, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account